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Numerous voxel-based morphometry (VBM) studies on gray matter (GM) of patients with
progressive supranuclear palsy (PSP) and Parkinson’s disease (PD) have been conducted
separately. Identifying the different neuroanatomical changes in GM resulting from PSP
and PD through meta-analysis will aid the differential diagnosis of PSP and PD. In this
study, a systematic review of VBM studies of patients with PSP and PD relative to
healthy control (HC) in the Embase and PubMed databases from January 1995 to April
2013 was conducted. The anatomical distribution of the coordinates of GM differences
was meta-analyzed using anatomical likelihood estimation. Separate maps of GM changes
were constructed and subtraction meta-analysis was performed to explore the differences
in GM abnormalities between PSP and PD. Nine PSP studies and 24 PD studies were
included. GM reductions were present in the bilateral thalamus, basal ganglia, midbrain,
insular cortex and inferior frontal gyrus, and left precentral gyrus and anterior cingulate
gyrus in PSP. Atrophy of GM was concentrated in the bilateral middle and inferior frontal
gyrus, precuneus, left precentral gyrus, middle temporal gyrus, right superior parietal
lobule, and right cuneus in PD. Subtraction meta-analysis indicated that GM volume
was lesser in the bilateral midbrain, thalamus, and insula in PSP compared with that
in PD. Our meta-analysis indicated that PSP and PD shared a similar distribution of
neuroanatomical changes in the frontal lobe, including inferior frontal gyrus and precentral
gyrus, and that atrophy of the midbrain, thalamus, and insula are neuroanatomical markers
for differentiating PSP from PD.
Keywords: progressive supranuclear palsy, Parkinson’s disease, subtraction meta-analysis, anatomic likelihood
estimation, voxel-based morphometry, gray matter volume
INTRODUCTION
Progressive supranuclear palsy (PSP) is an atypical Parkinsonism
neurodegenerative disease that often affects adults between 60
and 65 years of age (Armstrong, 2007). PSP is characterized
by progressive vertical gaze palsy, early postural instability with
falls, late frontal cognitive dysfunction, and poor response to lev-
odopa (Barsottini et al., 2010; Hirano et al., 2010; Stamelou et al.,
2010). Recent studies have suggested that the morbidity of PSP
may be higher than is usually considered (Nath et al., 2001).
Parkinson’s disease (PD), the second most common neurodegen-
erative disease, is characterized by rigidity, tremor, bradykinesia,
and posture instability (Tanner and Goldman, 1996). Although
symptoms such as vertical gaze palsy and early falls are specific to
PSP, differential diagnosis from PD can still be difficult at early
stages (Nilsson et al., 2007; Varrone et al., 2007).
Structural magnetic resonance imaging (MRI), functional
MRI (fMRI), and positron emission tomography (PET) are
increasingly being used in the differential diagnosis of PD and
related disorders (Juh et al., 2004). Voxel-based morphometry
(VBM), a time-efficient and automated tool, can reveal mor-
phological changes throughout the whole brain on a voxel-wise
basis (Ashburner and Friston, 2000). VBM has been widely
used in studies on PSP and PD (Brenneis et al., 2004; Burton
et al., 2004; Beyer et al., 2007; Agosta et al., 2010). However, the
results of VBM studies are controversial or not completely consis-
tent because of small and heterogeneous samples of participants
and substantial methodological differences among studies. For
example, some researchers (Agosta et al., 2010; Lehericy et al.,
2010) have reported cerebellum atrophy in PSP, whereas oth-
ers (Brenneis et al., 2004; Boxer et al., 2006) did not find such
abnormalities in PSP. Similarly, some articles (Focke et al., 2011;
Fernández-Seara et al., 2012) have reported precuneus impair-
ment in PD, whereas others (Dalaker et al., 2010; Hong et al.,
2012) failed to replicate such findings in PD. Thus, the appli-
cation of meta-analysis to identify consistent results of VBM
studies on PSP and PD has gained increasing interest. We pub-
lished a VBM meta-analysis on PD in 2012, which included
articles from 1995 to 25 October 2010 (Pan et al., 2012). As
more VBM studies on PD published since then, we updated the
results of meta-analysis on PD to explore more accurate GM
changes in PD.
The anatomic likelihood estimate (ALE) method, a newly
developed statistical technique, is a powerful voxel-based meta-
analytic technique originally designed for functional neu-
roimaging studies (Turkeltaub et al., 2002; Laird et al., 2005).
However, ALE has been effectively applied to anatomical
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image datasets, such as VBM and diffusion tensor imag-
ing studies (Ellison-Wright et al., 2008; Ellison-Wright and
Bullmore, 2009). Identifying consistent structural abnormali-
ties may provide insight into the pathophysiology of PSP and
PD. PSP can be easily misdiagnosed as PD. Given that the
midbrain and thalamus are reportedly more severely dam-
aged in PSP, and that the impairment of these two areas
contributes to classical symptoms, such as vertical gaze palsy
(Kato et al., 2003) and postural instability (Zwergal et al.,
2011), we speculated that atrophy of the midbrain and thala-
mus may be a neuroanatomical marker for the differentiation
of PSP from PD. Therefore, subtracting the results of meta-
analysis of PSP and PD will reveal the difference in pattern
change between PD and PSP, thus confirming our abovemen-
tioned hypothesis and increasing diagnostic accuracy in clinical
practice.
This study aimed to identify the consistent finding of gray
matter volume (GMV) changes in PSP and PD separately using
the ALE approach (Turkeltaub et al., 2002; Laird et al., 2005).
Contrast analysis was performed through ALE subtraction anal-
ysis (Eickhoff et al., 2011) to identify the differential pattern of
GMV changes between PSP and PD.
MATERIALS AND METHODS
DATA SOURCES AND STUDY SELECTION
Systematic and comprehensive searches were conducted on
the Embase and PubMed databases from January 1995 to
April 2013 using the following key words: (“voxel,” “voxel-
based,” “voxel-wise,” “morphometry,” “VBM,”) and (“PSP,”
“Steele–Richardson–Olszewski syndrome,” “ophthalmoplegia,”
“Parkinson,” “Parkinsonism,” “Paralysis Agitans,” and “PD”). The
reference lists of relevant papers were also searched for additional
studies.
Studies were included if they met the following criteria: (1)
reported on VBM as applied to GM density (GMD) or GMV
changes from a comparison of PSP and healthy control (HC), or
comparison of PD and HC (PD-HC), or comparison of PSP and
PD (PSP-PD); (2) reported whole-brain GM changes in standard
Talairach or Montreal Neurological Institute (MNI) stereotac-
tic spatial coordinates; (3) used significance thresholds that are
either corrected for multiple comparisons or uncorrected but
with spatial extent thresholds; (4) were published in English with
peer review. For studies that met the aforementioned inclusion
criteria and were performed by the same authors or research
institution, only the study with the largest sample size was
selected.
Studies were excluded if they suffered from at least one of the
following deficiencies: (1) sufficient data could not be obtained
even after corresponding with author/s by email or phone; (2) the
data overlapped with those of another article.
The method used in the current study was based on
the guidelines of “Meta-analysis of Observational Studies in
Epidemiology” for the meta-analysis of observational studies
(Stroup et al., 2000).
Study selection was performed by one author (Na Shao) and
verified by another author (Jing Yang) independently. The process
of study selection was provided in Figure 1.
FIGURE 1 | Flow-chart of searching strategy.
DATA EXTRACTION
Ginger ALE (http://brainmap.org/ale/index.html) was used to
transform reported coordinates into the stereotactic space of
Talairach. Reported coordinates in a stereotactic space of theMNI
were converted to Talairach coordinates using Lancaster trans-
form (Lancaster et al., 2007). Reported coordinates transformed
to Talairach space using the Brett transformation (Brett et al.,
2002) were converted back to MNI space and then reconverted to
Talairach also using the Lancaster formula (Lancaster et al., 2007).
Two authors (Na Shao and Jing Yang) performed data extraction
independently.
META-ANALYSIS OF VBM STUDIES
Meta-analysis was performed using Ginger ALE software 2.1.1
(http://www.brainmap.org) and the Talairach stereotactic coor-
dinates derived from the included articles (Eickhoff et al., 2012).
The reported coordinates were modeled using a 3D Gaussian
distribution defined by full width at half maximum (FWHM)
(Laird et al., 2005). The FWHM was set according to a quan-
titative uncertainty model (Eickhoff et al., 2009). Separate ALE
maps were created for multiple comparisons associated with
PSP–HC and PD–HC. Afterward, in order to identify the dif-
ferential pattern of GMV changes between PSP and PD, ALE
subtraction analysis (Eickhoff et al., 2011) evaluating the dif-
ferences between the ALE maps of PSP–HC and PD–HC was
carried out, taking into account the potential difference in the
sample size. These maps were thresholded at p < 0.05 corrected
for multiple comparisons using False Discovery Rate (Benjamini
and Hochberg, 1995). An extent-threshold of 100mm3 was
applied. The coordinates of the weighted center were generated
for each cluster. The resulting significant anatomical areas were
labeled by referring to probabilistic cytoarchitectonic maps of the
human brain using the SPM Anatomy Toolbox v1.8 (Eickhoff
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et al., 2005). This labeling presented the attribution of each
voxel of the reference space to the most likely cytoarchitectonic
area (Eickhoff et al., 2005). Rest software was used to visu-
alize the ALE maps overlaid onto an average brain template
MNI/ICBM 152 (http://www.bic.mni.mcgill.ca/ServicesAtlases/
ICBM152NLin2009).
RESULTS
PSP< HC
We identified 32 studies in the database searches (Figure 1)
including nine PSP-HC articles (Brenneis et al., 2004; Cordato
et al., 2005; Boxer et al., 2006; Padovani et al., 2006; Agosta
et al., 2010; Lehericy et al., 2010; Takahashi et al., 2011;
Ghosh et al., 2012; Giordano et al., 2013). One hundred
and fourty-five PSP patients and 217 HC were included in
this study and a total of 104 foci with reduced GMV were
reported. The main characteristics of the included participants
are presented in Table 1. Thirty PSP patients from two stud-
ies had mild cognitive impairment (Padovani et al., 2006;
Takahashi et al., 2011). GM reduction was observed in the bilat-
eral thalamus, midbrain, insula, basal ganglia, inferior frontal
gyrus, left precentral gyrus, and the left anterior cingulate
by using the ALE approach (Figure 2). No increased GMV
relative to HC was observed in the brain regions of PSP
patients. Similar findings were revealed after excluding two stud-
ies conducted on PSP patients with mild cognitive impairment
(Padovani et al., 2006; Takahashi et al., 2011) (Supplemental
Figure 1).
PD< HC
Thirty-two studies were identified in the meta-analysis (Figure 1)
and a total of 24 studies on PD were included (Burton et al.,
2004; Cordato et al., 2005; Nagano-Saito et al., 2005; Beyer et al.,
2007; Ramirez-Ruiz et al., 2007; Feldmann et al., 2008; Karagulle
Kendi et al., 2008; Camicioli et al., 2009; Jubault et al., 2009;
Martin et al., 2009; Pereira et al., 2009; Sanchez-Castaneda et al.,
2009; Tir et al., 2009; Dalaker et al., 2010; Kostic et al., 2010; Lee
et al., 2010; Cerasa et al., 2011; Focke et al., 2011; Meppelink
et al., 2011; Compta et al., 2012; Fernández-Seara et al., 2012;
Hong et al., 2012; Ibarretxe-Bilbao et al., 2012; Tessitore et al.,
2012). Seven hundred and sixteen PD patients and 535 HC
subjects met the inclusion criteria for meta-analysis. The main
characteristics of these included populations are presented in
Table 2. Among these participants, 60 patients from three stud-
ies had mild cognitive impairment (Beyer et al., 2007; Dalaker
et al., 2010; Lee et al., 2010) and 16 patients from one study
had dementia (Sanchez-Castaneda et al., 2009). A total of 117
foci presented with decreased GMV were reported. ALE meta-
analysis identified reduced GMV in the following: (1) frontal
lobe including the bilateral middle, inferior frontal gyrus, and
left precentral gyrus, (2) parietal lobe including bilateral pre-
cuneus and right superior parietal lobule, and (3) left middle
temporal gyrus and right cuneus (Figure 2). No increased regions
relative to HC were found in PD patients. Similar findings were
obtained after excluding the aforementioned four studies con-
ducted on PD patients with cognitive impairment (Supplemental
Figure 1). Ta
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PSP< PD
Given that only two of three studies (Cordato et al., 2005; Focke
et al., 2011; Giordano et al., 2013) directly investigated GMV
differences between PSP and PD using the whole brain coordi-
nate (Focke et al., 2011; Giordano et al., 2013), meta-analysis
was not highly reliable. Therefore, ALE subtraction analysis
was performed to compare GM differences between PSP and
PD (Eickhoff et al., 2011). The subtraction analysis identified
decreased GMV in the bilateral midbrain, thalamus, and insula in
PSP compared with PD (Table 3 and Figure 2). The reverse con-
trast did not show any regions of GM atrophy. Similar findings
were found using subtraction analysis between PSP (non-MCI)
and PD (non-MCI) studies without including patients with mild
cognitive impairment or dementia (Supplemental Figure 1).
DISCUSSION
Quantitative meta-analysis of VBM studies on PSP showed
decreased GMV in the thalamus, midbrain, basal ganglia, insula,
and frontal lobe, whereas quantitative meta-analysis of VBM
studies on PD revealed reduced GMV in the frontal lobe, parietal
lobe, left middle temporal gyrus, and right cuneus. In addi-
tion, subtraction analysis showed GM atrophy in the thalamus,
midbrain, and insula lobe in PSP compared with PD.
In this study, reduced GMV in PD was observed in the fol-
lowing: (1) frontal lobe including bilateral middle, inferior frontal
gyrus, and left precentral gyrus, (2) parietal lobe including bilat-
eral precuneus and right superior parietal lobule, and (3) left
middle temporal gyrus and right cuneus. The previous results
showed changes in PD localized in the left inferior frontal gyrus,
left superior temporal gyrus, and left insula lobe (Pan et al.,
2012). The main results are consistent. The differences between
the present findings and those of previous VBM studies on PD
may be the result of the difference in methods (“signed differen-
tial mapping” method was used in our previous study and ALE
method was used in the present study) and number of partici-
pants (498 PD patients and 375 HCwere included in our previous
study, whereas 716 PD patients and 535 HC were included in the
present study).
We found decreased GMV in the frontal lobe, including infe-
rior frontal gyrus and precentral gyrus in both PSP and PD. These
results are supported by some fMRI and pathological studies
(Albers et al., 2000;Whitwell et al., 2011; Kehagia et al., 2012; Yang
et al., 2013). The precentral gyrus belongs to the motor cortex
and is the origin of the pyramidal tract (Bonelli and Cummings,
2007). Additionally, the inferior frontal gyrus (Brodmann area
44), affects movement control, including speech and hand actions
(Rizzolatti et al., 2002; Bonelli and Cummings, 2007). It also par-
ticipates in response inhibition (Picton et al., 2007; Forstmann
et al., 2008). Therefore, the impairment of the precentral gyrus
and inferior frontal gyrus may partially contribute to the motor
and non-motor deficits of both disorders.
Interestingly, GM atrophy in the bilateral midbrain, thalamus,
and insula was found to be more severe in PSP than in PD,
although no significant foci were revealed in these structures in
the meta-analysis of VBM studies on PD. The pathological hall-
marks of PSP include globose neurofibrillary tangles, tufted tau-
positive astrocytes, and neuronal loss in the midbrain (Dickson
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FIGURE 2 | Gray matter volume changes betweeen different groups. PSP,
gray matter decreases in patients with progressive supranuclear palsy
relative to healthy control; PD, gray matter decreases in patients with
Parkinson’s disease relative to healthy control; PSP < PD, diminished gray
matter volume in progressive supranuclear palsy patients relative to
Parkinson’s disease patients. Significance thresholded with a false discovery
rate at P < 0.05 and a cluster extent threshold of 100 voxels; z, z coordinates
in Talairach space; L, left; R, right.
et al., 2007; Williams and Lees, 2009). The midbrain not only
maintains equilibrium (Barsottini et al., 2010), but also has a role
in vertical saccades (Da Cunha et al., 2002; Kato et al., 2003).
More severe atrophy of the midbrain can contribute to distur-
bances in balance and vertical gaze movement in PSP. Although
dopaminergic neuron loss in the substantia nigra in PD was
found to be the main pathology in PD (Halliday et al., 1996),
we failed to find midbrain atrophy in PD by means of VBM
meta-analysis. Therefore, severe atrophy of the midbrain could be
a neuroanatomical marker that can be used to differentiate PSP
from PD.
Subtraction analysis showed that GMV reductions in the
bilateral thalamus are more severe in PSP patients compared
with PD patients. Atrophy of the thalamus revealed in PSP
in the current meta-analysis of VBM studies is consistent
with the findings of studies using PET (Juh et al., 2005) and
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Table 3 | Changes in gray matter volume.
Cluster No. Volume Talairach coordinates Macroanatomical and cytoarchitectonic
region
Contributors
(mm3) (weighted center)
X Y Z
PSP < HC
1 4008 0.19 −23.61 6.47 Thalamus (th-temporal, th-prefrontal; left
and right lobe); red nucleus (left and right
lobe)
Cordato et al., 2005; Boxer et al., 2006;
Padovani et al., 2006; Agosta et al., 2010;
Lehericy et al., 2010
2 2048 −39.31 7.98 10.27 Insula (left lobe); inferior frontal gyrus
(BA44, left lobe); precentral gyrus (left
lobe)
Brenneis et al., 2004; Cordato et al., 2005;
Boxer et al., 2006; Padovani et al., 2006;
Agosta et al., 2010; Takahashi et al., 2011
3 1296 38. 3 14.83 11.13 Insula (BA13, right lobe); inferior frontal
gyrus (BA44, right lobe)
Brenneis et al., 2004; Boxer et al., 2006;
Padovani et al., 2006; Ghosh et al., 2012
4 328 37.01 −4.24 10.12 Insula (BA13, right lobe); claustrum (right
lobe)
Agosta et al., 2010; Ghosh et al., 2012
5 216 −10.31 1.04 16.78 Caudate nucleus (left lobe) Cordato et al., 2005; Agosta et al., 2010
6 160 −1.91 44.47 6.52 Anterior cingulate cortex (left lobe) Brenneis et al., 2004; Agosta et al., 2010
PD < HC
1 608 −28.61 −10.08 58.63 Middle frontal gyrus (BA6, left lobe) Fernández-Seara et al., 2012; Hong et al.,
2012
2 448 42.89 36.64 11.38 Inferior frontal gyrus (BA46; right lobe) Burton et al., 2004; Pereira et al., 2009
3 432 −27.02 −76.51 36.43 Precuneus (BA19; left lobe) Ramirez-Ruiz et al., 2007; Meppelink et al.,
2011; Hong et al., 2012
4 360 −42.82 19.14 −12.1 Inferior frontal gyrus (BA47; left lobe) Ramirez-Ruiz et al., 2007; Pereira et al.,
2009; Meppelink et al., 2011
5 304 −42.45 6.47 39.69 Middle frontal gyrus (left lobe) Pereira et al., 2009; Kostic et al., 2010
6 272 31.77 31.64 31.7 Middle frontal gyrus (right lobe) Burton et al., 2004; Ramirez-Ruiz et al.,
2007
7 264 −13.58 −29.91 67.51 Precentral gyrus (BA 6,4a; left lobe) Fernández-Seara et al., 2012
8 256 4.07 −71.39 22.06 Precuneus (right lobe); cuneus (right lobe) Lee et al., 2010; Compta et al., 2012
9 248 16.78 −52.38 62.58 Superior parietal lobule (5L, 7PC, 5M; right
lobe)
Pereira et al., 2009; Meppelink et al., 2011
10 240 −57.21 −44.53 −12.42 Middle temporal gyrus (left lobe) Pereira et al., 2009; Hong et al., 2012
11 200 46.04 20.42 0.93 Inferior frontal gyrus (BA47; right lobe);
superior parietal lobule (7A; right lobe)
Burton et al., 2004; Pereira et al., 2009
12 200 0.32 −64.31 47.8 Precuneus (BA7; left lobe) Pereira et al., 2009; Compta et al., 2012
13 120 32.13 31.85 −3.55 Inferior frontal gyrus (BA47; right lobe) Dalaker et al., 2010; Meppelink et al., 2011
PSP < PD
1 3928 −0.09 −23.36 6.47 Thalamus (th-temporal, th-prefrontal; left
and right lobe); red nucleus (left and right
lobe)
Cordato et al., 2005; Boxer et al., 2006;
Padovani et al., 2006; Agosta et al., 2010;
Lehericy et al., 2010
2 1608 −37.63 9.03 10.24 Insula (BA13; left lobe) Brenneis et al., 2004; Cordato et al., 2005;
Boxer et al., 2006; Padovani et al., 2006;
Agosta et al., 2010; Takahashi et al., 2011
3 280 37.26 17.33 10.97 Insula (BA13; right lobe) Padovani et al., 2006
No., number; PSP, progressive supranuclear palsy; HC, healthy control; PD, Parkinson’s disease; th-, thalamus; BA, Brodmann area.
single-photon emission computed tomography (Kimura et al.,
2011). Pathological research on PSP also confirmed that the tha-
lamus often exhibits some degree of neuronal loss and gliosis,
particularly in the lateral and ventral anterior thalamus nuclei
(Dickson et al., 2007). Postural instability in PSP patients has been
associated with impairment of the thalamus (Zwergal et al., 2011),
which has a significant role in motor functions through both
functional and structural connections with the basal ganglia and
motor regions of the frontal lobe (Herrero et al., 2002; Cordato
et al., 2005; Bonelli and Cummings, 2007). Although altered tha-
lamic neuronal activity in the cortical-striatal-thalamic loop is
the main pathophysiology in PD (Halliday, 2009), the present
study found no obvious thalamus atrophy in PD, confirming that
thalamus impairment in PD consists of functional deficits other
than structural changes. Our main findings stayed consistent after
excluding PSP or PD patients with cognitive impairment, we can
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not, suggest that the thalamus may not be closely related to the
cognitive impairment of PD or PSP patients since these PSP or PD
patients with cognitive impairment accounted for a small portion
of our patient samples. However, future studies on PSP or more
advanced PD patients will increase current understanding on the
impairment of the thalamus.
Interestingly, subtracting analysis showed that insula atrophy
was more severe in PSP than in PD. Very few articles have inves-
tigated the insula impairment of PSP. A previous PET study
found hypometabolism in the insula of PSP patients (Hirano
et al., 2010). Other studies have found that dysfunction of the
insula could lead to abnormalities in articulation and emotions
(Augustine, 1996; Baldo et al., 2011). Although some neuroimag-
ing studies using structural MRI, fMRI, or PET (Kikuchi et al.,
2001; Stefurak et al., 2003; Pinto et al., 2004; Pavese et al., 2010)
have reported insula damage in PD patients, these patients exhib-
ited fatigue or dysarthria. Most included studies on PD did not
provide detailed information on motor and non-motor symp-
toms, such as severity of dysarthria, static tremor, or fatigue,
which may partially explain why insula atrophy was not proved
in this study.
However, the finding of subtraction analysis in the current
study was different from the results of two VBM studies (Focke
et al., 2011; Giordano et al., 2013) which directly compared GMV
on PSP and PD, which found the atrophy was more severe in
cerebellum, parahippocampal gyrus, middle frontal gyrus, occip-
ital pole, and precentral gyrus in PSP than PD. However, the
sample size of these two studies was relatively small. Future
large sample size comparison studies on PSP–PD with multi-
modal imaging techniques will help to answer the difference.
This study has several limitations, which could have biased our
results. First, unpublished studies and studies with insufficient
data were excluded, and the studies were limited to those pub-
lished in English. Second, the voxel-wise meta-analyses were
based on the reported stereotactic coordinates with significant
differences rather than on raw data, and the included patients
from different studies may have experienced various severities
of disease or therapy, thereby potentially influencing the results.
Third, the heterogeneity of the methodologies used in VBM stud-
ies, including different expression of GM changes (modulated
GMV and unmodulated GMD), FWHMand statistical threshold-
ing methods, could not be ruled out entirely. Additionally, PSP
is classified into Richardson syndrome and PSP-Parkinsonism
(PSP-P) according to different clinical signs (Williams et al.,
2005). Given that only two articles (Agosta et al., 2010; Lehericy
et al., 2010) mention the phenotypes, we could not perform
separate meta-analysis of each phenotype or between PSP-P
and PD.
In summary, the present meta-analysis indicated that both
PSP and PD patients suffer from GM atrophy in the precentral
gyrus and inferior frontal gyrus. GM atrophy was also identified
in the bilateral midbrain, thalamus, and insula in PSP patients
compared with PD patients, and could thus be an anatomical
biomarker that can be used to differentiate these two disorders.
Future studies with larger samples of patients in the early stage of
disease, as well as multimodal methods, may better expound the
changes.
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